{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T18:35:20Z","timestamp":1775586920808,"version":"3.50.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,26]],"date-time":"2019-11-26T00:00:00Z","timestamp":1574726400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,11,26]],"date-time":"2019-11-26T00:00:00Z","timestamp":1574726400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA193965"],"award-info":[{"award-number":["R01 CA193965"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA 158119, R35 CA197605"],"award-info":[{"award-number":["R01 CA 158119, R35 CA197605"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P01 CA087969"],"award-info":[{"award-number":["P01 CA087969"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Cancer Antigen 125 (CA125) is currently the best available ovarian cancer screening biomarker. However, CA125 has been limited by low sensitivity and specificity in part due to normal variation between individuals. Personal characteristics that influence CA125 could be used to improve its performance as screening biomarker.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>We developed and validated linear and dichotomous (\u226535\u2009U\/mL) circulating CA125 prediction models in postmenopausal women without ovarian cancer who participated in one of five large population-based studies: Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO, <jats:italic>n<\/jats:italic>\u2009=\u200926,981), European Prospective Investigation into Cancer and Nutrition (EPIC, <jats:italic>n<\/jats:italic>\u2009=\u2009861), the Nurses\u2019 Health Studies (NHS\/NHSII, <jats:italic>n<\/jats:italic>\u2009=\u200981), and the New England Case Control Study (NEC, <jats:italic>n<\/jats:italic>\u2009=\u2009923). The prediction models were developed using stepwise regression in PLCO and validated in EPIC, NHS\/NHSII and NEC.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Result<\/jats:title>\n<jats:p>The linear CA125 prediction model, which included age, race, body mass index (BMI), smoking status and duration, parity, hysterectomy, age at menopause, and duration of hormone therapy (HT), explained 5% of the total variance of CA125. The correlation between measured and predicted CA125 was comparable in PLCO testing dataset (r\u2009=\u20090.18) and external validation datasets (r\u2009=\u20090.14). The dichotomous CA125 prediction model included age, race, BMI, smoking status and duration, hysterectomy, time since menopause, and duration of HT with AUC of 0.64 in PLCO and 0.80 in validation dataset.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>The linear prediction model explained a small portion of the total variability of CA125, suggesting the need to identify novel predictors of CA125. The dichotomous prediction model showed moderate discriminatory performance which validated well in independent dataset. Our dichotomous model could be valuable in identifying healthy women who may have elevated CA125 levels, which may contribute to reducing false positive tests using CA125 as screening biomarker.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s13048-019-0591-4","type":"journal-article","created":{"date-parts":[[2019,11,26]],"date-time":"2019-11-26T07:02:39Z","timestamp":1574751759000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Development and validation of circulating CA125 prediction models in postmenopausal women"],"prefix":"10.1186","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4526-2181","authenticated-orcid":false,"given":"Naoko","family":"Sasamoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Babic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard A.","family":"Rosner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ren\u00e9e T.","family":"Fortner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allison F.","family":"Vitonis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidemi","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raina N.","family":"Fichorova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda J.","family":"Titus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Tj\u00f8nneland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louise","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Kvaskoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agn\u00e8s","family":"Fournier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca Romana","family":"Mancini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heiner","family":"Boeing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonia","family":"Trichopoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleni","family":"Peppa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Karakatsani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Domenico","family":"Palli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Grioni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amalia","family":"Mattiello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosario","family":"Tumino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Fiano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N. Charlotte","family":"Onland-Moret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabete","family":"Weiderpass","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inger T.","family":"Gram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Ram\u00f3n","family":"Quir\u00f3s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leila","family":"Lujan-Barroso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria-Jose","family":"S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Colorado-Yohar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aurelio","family":"Barricarte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pilar","family":"Amiano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annika","family":"Idahl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Lundin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanna","family":"Sartor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kay-Tee","family":"Khaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy J.","family":"Key","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Muller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elio","family":"Riboli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Gunter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laure","family":"Dossus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Britton","family":"Trabert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Wentzensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rudolf","family":"Kaaks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel W.","family":"Cramer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shelley S.","family":"Tworoger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn L.","family":"Terry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,11,26]]},"reference":[{"key":"591_CR1","doi-asserted-by":"publisher","first-page":"4183","DOI":"10.1096\/fj.14-257352","volume":"28","author":"D Haridas","year":"2014","unstructured":"Haridas D, Ponnusamy MP, Chugh S, Lakshmanan I, Seshacharyulu P, Batra SK. MUC16: molecular analysis and its functional implications in benign and malignant conditions. FASEB J. 2014;28:4183\u201399.","journal-title":"FASEB J"},{"key":"591_CR2","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1093\/jnci\/djp438","volume":"102","author":"GL Anderson","year":"2010","unstructured":"Anderson GL, McIntosh M, Wu L, Barnett M, Goodman G, Thorpe JD, et al. Assessing lead time of selected ovarian cancer biomarkers: a nested case-control study. J Natl Cancer Inst. 2010;102:26\u201338.","journal-title":"J Natl Cancer Inst"},{"key":"591_CR3","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ygyno.2010.06.003","volume":"119","author":"JO Schorge","year":"2010","unstructured":"Schorge JO, Modesitt SC, Coleman RL, Cohn DE, Kauff ND, Duska LR, et al. SGO white paper on ovarian cancer: etiology, screening and surveillance. Gynecol Oncol. 2010;119:7\u201317.","journal-title":"Gynecol Oncol"},{"key":"591_CR4","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1056\/NEJM198310133091503","volume":"309","author":"RC Bast Jr","year":"1983","unstructured":"Bast RC Jr, Klug TL, St John E, Jenison E, Niloff JM, Lazarus H, et al. A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. N Engl J Med. 1983;309:883\u20137.","journal-title":"N Engl J Med"},{"key":"591_CR5","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1016\/j.ajog.2005.05.005","volume":"193","author":"SS Buys","year":"2005","unstructured":"Buys SS, Partridge E, Greene MH, Prorok PC, Reding D, Riley TL, et al. Ovarian cancer screening in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial: findings from the initial screen of a randomized trial. Am J Obstet Gynecol. 2005;193:1630\u20139.","journal-title":"Am J Obstet Gynecol"},{"key":"591_CR6","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/S0140-6736(15)01224-6","volume":"387","author":"IJ Jacobs","year":"2016","unstructured":"Jacobs IJ, Menon U, Ryan A, Gentry-Maharaj A, Burnell M, Kalsi JK, et al. Ovarian cancer screening and mortality in the UK collaborative trial of ovarian Cancer screening (UKCTOCS): a randomised controlled trial. Lancet. 2016;387:945\u201356.","journal-title":"Lancet."},{"key":"591_CR7","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13048-017-0315-6","volume":"10","author":"RT Fortner","year":"2017","unstructured":"Fortner RT, Vitonis AF, Schock H, Husing A, Johnson T, Fichorova RN, et al. Correlates of circulating ovarian cancer early detection markers and their contribution to discrimination of early detection models: results from the EPIC cohort. J Ovarian Res. 2017;10:20.","journal-title":"J Ovarian Res"},{"key":"591_CR8","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.ygyno.2008.05.006","volume":"110","author":"CC Johnson","year":"2008","unstructured":"Johnson CC, Kessel B, Riley TL, Ragard LR, Williams CR, Xu JL, et al. The epidemiology of CA-125 in women without evidence of ovarian cancer in the prostate, lung, colorectal and ovarian Cancer (PLCO) screening trial. Gynecol Oncol. 2008;110:383\u20139.","journal-title":"Gynecol Oncol"},{"key":"591_CR9","first-page":"489","volume":"10","author":"DK Pauler","year":"2001","unstructured":"Pauler DK, Menon U, McIntosh M, Symecko HL, Skates SJ, Jacobs IJ. Factors influencing serum CA125II levels in healthy postmenopausal women. Cancer Epidemiol Biomarkers Prev. 2001;10:489\u201393.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"591_CR10","first-page":"428","volume":"76","author":"C Westhoff","year":"1990","unstructured":"Westhoff C, Gollub E, Patel J, Rivera H, Bast R Jr. CA 125 levels in menopausal women. Obstet Gynecol. 1990;76:428\u201331.","journal-title":"Obstet Gynecol"},{"key":"591_CR11","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1093\/jnci\/djt281","volume":"105","author":"CS Zhu","year":"2013","unstructured":"Zhu CS, Pinsky PF, Kramer BS, Prorok PC, Purdue MP, Berg CD, et al. The prostate, lung, colorectal, and ovarian cancer screening trial and its associated research resource. J Natl Cancer Inst. 2013;105:1684\u201393.","journal-title":"J Natl Cancer Inst"},{"key":"591_CR12","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1079\/PHN2002394","volume":"5","author":"E Riboli","year":"2002","unstructured":"Riboli E, Hunt KJ, Slimani N, Ferrari P, Norat T, Fahey M, et al. European prospective investigation into Cancer and nutrition (EPIC): study populations and data collection. Public Health Nutr. 2002;5:1113\u201324.","journal-title":"Public Health Nutr"},{"key":"591_CR13","doi-asserted-by":"publisher","first-page":"4664","DOI":"10.1158\/1078-0432.CCR-16-0316","volume":"22","author":"KL Terry","year":"2016","unstructured":"Terry KL, Schock H, Fortner RT, Husing A, Fichorova RN, Yamamoto HS, et al. A prospective evaluation of early detection biomarkers for ovarian Cancer in the European EPIC cohort. Clin Cancer Res. 2016;22:4664\u201375.","journal-title":"Clin Cancer Res"},{"key":"591_CR14","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/nrc1608","volume":"5","author":"GA Colditz","year":"2005","unstructured":"Colditz GA, Hankinson SE. The Nurses' health study: lifestyle and health among women. Nat Rev Cancer. 2005;5:388\u201396.","journal-title":"Nat Rev Cancer"},{"key":"591_CR15","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1093\/jnci\/90.15.1155","volume":"90","author":"B Rockhill","year":"1998","unstructured":"Rockhill B, Willett WC, Hunter DJ, Manson JE, Hankinson SE, Spiegelman D, et al. Physical activity and breast cancer risk in a cohort of young women. J Natl Cancer Inst. 1998;90:1155\u201360.","journal-title":"J Natl Cancer Inst"},{"key":"591_CR16","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1093\/aje\/kwi064","volume":"161","author":"KL Terry","year":"2005","unstructured":"Terry KL, De Vivo I, Titus-Ernstoff L, Sluss PM, Cramer DW. Genetic variation in the progesterone receptor gene and ovarian cancer risk. Am J Epidemiol. 2005;161:442\u201351.","journal-title":"Am J Epidemiol"},{"key":"591_CR17","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1093\/jnci\/djs461","volume":"104","author":"AH Eliassen","year":"2012","unstructured":"Eliassen AH, Hendrickson SJ, Brinton LA, Buring JE, Campos H, Dai Q, et al. Circulating carotenoids and risk of breast cancer: pooled analysis of eight prospective studies. J Natl Cancer Inst. 2012;104:1905\u201316.","journal-title":"J Natl Cancer Inst"},{"key":"591_CR18","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1002\/sim.4780080504","volume":"8","author":"S Durrleman","year":"1989","unstructured":"Durrleman S, Simon R. Flexible regression models with cubic splines. Stat Med. 1989;8:551\u201361.","journal-title":"Stat Med"},{"key":"591_CR19","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1111\/j.1467-9248.2009.00813.x","volume":"58","author":"KA Clarke","year":"2010","unstructured":"Clarke KA, Signorino CS. Discriminating methods: tests for nonnested discrete choice models. Pol Stud. 2010;58:368\u201388.","journal-title":"Pol Stud"},{"key":"591_CR20","doi-asserted-by":"publisher","first-page":"2480","DOI":"10.1158\/1055-9965.EPI-08-0150","volume":"17","author":"KA Lowe","year":"2008","unstructured":"Lowe KA, Shah C, Wallace E, Anderson G, Paley P, McIntosh M, et al. Effects of personal characteristics on serum CA125, mesothelin, and HE4 levels in healthy postmenopausal women at high-risk for ovarian cancer. Cancer Epidemiol Biomarkers Prev. 2008;17:2480\u20137.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"Suppl 1","key":"591_CR21","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1097\/IGC.0b013e318251c97d","volume":"22","author":"RC Bast Jr","year":"2012","unstructured":"Bast RC Jr, Skates S, Lokshin A, Moore RG. Differential diagnosis of a pelvic mass: improved algorithms and novel biomarkers. Int J Gynecol Cancer. 2012;22(Suppl 1):S5\u20138.","journal-title":"Int J Gynecol Cancer"},{"key":"591_CR22","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13048-016-0254-7","volume":"9","author":"KM Terlikowska","year":"2016","unstructured":"Terlikowska KM, Dobrzycka B, Witkowska AM, Mackowiak-Matejczyk B, Sledziewski TK, Kinalski M, et al. Preoperative HE4, CA125 and ROMA in the differential diagnosis of benign and malignant adnexal masses. J Ovarian Res. 2016;9:43.","journal-title":"J Ovarian Res"},{"key":"591_CR23","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1001\/jama.2017.21926","volume":"319","author":"USPST Force","year":"2018","unstructured":"Force USPST, Grossman DC, Curry SJ, Owens DK, Barry MJ, Davidson KW, et al. Screening for ovarian Cancer: US preventive services task Force recommendation statement. JAMA. 2018;319:588\u201394.","journal-title":"JAMA"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-019-0591-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13048-019-0591-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-019-0591-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,25]],"date-time":"2020-11-25T00:27:19Z","timestamp":1606264039000},"score":1,"resource":{"primary":{"URL":"https:\/\/ovarianresearch.biomedcentral.com\/articles\/10.1186\/s13048-019-0591-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,26]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["591"],"URL":"https:\/\/doi.org\/10.1186\/s13048-019-0591-4","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,26]]},"assertion":[{"value":"24 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study protocol was approved by the Institutional Review Board of the Brigham and Women\u2019s Hospital, Boston, Massachusetts (2017P000012).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"116"}}